| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.859 | 0.004 | 0.859 | Antiadrenergic | 0.191 0.026 DBMET03286 0.265 0.016 DBMET03287 0.265 0.016 DBMET03288 0.083 0.068 DBMET03289 | ||
| 0.858 | 0.004 | 0.858 | Adrenaline antagonist | 0.189 0.026 DBMET03286 0.264 0.016 DBMET03287 0.264 0.016 DBMET03288 0.081 0.067 DBMET03289 | ||
| 0.755 | 0.004 | 0.755 | Vasodilator, peripheral | 0.663 0.009 DBMET03286 0.539 0.022 DBMET03287 0.539 0.022 DBMET03288 0.64 0.012 DBMET03289 | ||
| 0.744 | 0.005 | 0.744 | 5 Hydroxytryptamine release stimulant | 0.526 0.023 DBMET03286 0.448 0.036 DBMET03287 0.448 0.036 DBMET03288 0.382 0.049 DBMET03289 | ||
| 0.69 | 0.005 | 0.69 | Cardiotonic | 0.37 0.035 DBMET03286 0.273 0.068 DBMET03287 0.273 0.068 DBMET03288 0.185 0.134 DBMET03289 | ||
| 0.637 | 0.002 | 0.637 | Beta adrenoreceptor antagonist | 0.095 0.019 DBMET03286 0.153 0.005 DBMET03287 0.153 0.005 DBMET03288 0.06 0.055 DBMET03289 | ||
| 0.591 | 0.008 | 0.689 | Vasodilator, coronary | 0.689 0.005 DBMET03286 0.304 0.084 DBMET03287 0.304 0.084 DBMET03288 0.539 0.011 DBMET03289 | DBMET03286 | |
| 0.595 | 0.013 | 0.595 | Spasmolytic | 0.501 0.023 DBMET03286 0.307 0.067 DBMET03289 | ||
| 0.538 | 0.002 | 0.538 | Beta 1 adrenoreceptor antagonist | 0.062 0.034 DBMET03286 0.128 0.006 DBMET03287 0.128 0.006 DBMET03288 | ||
| 0.529 | 0.001 | 0.529 | Beta 3 adrenoreceptor antagonist | 0.081 0.023 DBMET03286 0.209 0.004 DBMET03287 0.209 0.004 DBMET03288 0.066 0.04 DBMET03289 | ||
| 0.519 | 0.008 | 0.519 | Peroxidase inhibitor | 0.507 0.009 DBMET03287 0.507 0.009 DBMET03288 | ||
| 0.527 | 0.025 | 0.527 | 5 Hydroxytryptamine release inhibitor | 0.469 0.043 DBMET03286 0.402 0.077 DBMET03287 0.402 0.077 DBMET03288 0.467 0.044 DBMET03289 | ||
| 0.473 | 0.014 | 0.473 | Vasodilator | 0.466 0.015 DBMET03286 0.238 0.077 DBMET03287 0.238 0.077 DBMET03288 0.376 0.027 DBMET03289 | ||
| 0.459 | 0.002 | 0.459 | Beta 2 adrenoreceptor antagonist | 0.058 0.026 DBMET03286 0.088 0.009 DBMET03287 0.088 0.009 DBMET03288 | ||
| 0.466 | 0.042 | 0.522 | Histamine release inhibitor | 0.522 0.022 DBMET03286 0.3 0.124 DBMET03287 0.3 0.124 DBMET03288 0.517 0.024 DBMET03289 | DBMET03286 | |
| 0.415 | 0.013 | 0.415 | Sodium/bile acid cotransporter inhibitor | 0.349 0.04 DBMET03286 0.308 0.072 DBMET03287 0.308 0.072 DBMET03288 0.283 0.095 DBMET03289 | ||
| 0.392 | 0.003 | 0.392 | Adrenaline agonist | 0.105 0.034 DBMET03287 0.105 0.034 DBMET03288 | ||
| 0.386 | 0.019 | 0.386 | Cyclic AMP phosphodiesterase inhibitor | 0.35 0.026 DBMET03286 0.266 0.056 DBMET03289 | ||
| 0.428 | 0.064 | 0.428 | Calcium channel L-type activator | 0.292 0.164 DBMET03286 0.364 0.107 DBMET03287 0.364 0.107 DBMET03288 0.253 0.202 DBMET03289 | ||
| 0.362 | 0.015 | 0.41 | DNA methylase inhibitor | 0.41 0.01 DBMET03286 0.135 0.132 DBMET03287 0.135 0.132 DBMET03288 0.25 0.048 DBMET03289 | DBMET03286 | |
| 0.37 | 0.028 | 0.37 | Psychostimulant | 0.253 0.058 DBMET03286 0.167 0.102 DBMET03289 | ||
| 0.344 | 0.009 | 0.344 | Anesthetic local | |||
| 0.341 | 0.006 | 0.341 | Nav1.3 sodium channel blocker | |||
| 0.411 | 0.091 | 0.411 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.301 0.211 DBMET03287 0.301 0.211 DBMET03288 | ||
| 0.312 | 0.004 | 0.312 | 5 Hydroxytryptamine 3E antagonist | 0.257 0.013 DBMET03287 0.257 0.013 DBMET03288 | ||
| 0.313 | 0.022 | 0.313 | DNA methyltransferase I inhibitor | 0.297 0.027 DBMET03286 0.185 0.077 DBMET03289 | ||
| 0.394 | 0.114 | 0.394 | Caspase 9 stimulant | 0.375 0.127 DBMET03286 0.274 0.224 DBMET03287 0.274 0.224 DBMET03288 0.327 0.166 DBMET03289 | ||
| 0.291 | 0.031 | 0.291 | P-glycoprotein inhibitor | 0.173 0.086 DBMET03286 0.145 0.125 DBMET03287 0.145 0.125 DBMET03288 0.169 0.091 DBMET03289 | ||
| 0.292 | 0.039 | 0.292 | Gastrin inhibitor | 0.222 0.116 DBMET03286 | ||
| 0.312 | 0.063 | 0.312 | Aldehyde oxidase inhibitor | 0.152 0.138 DBMET03287 0.152 0.138 DBMET03288 | ||
| 0.334 | 0.095 | 0.334 | Antiobesity | 0.236 0.171 DBMET03286 | ||
| 0.288 | 0.051 | 0.432 | Interleukin antagonist | 0.432 0.026 DBMET03287 0.432 0.026 DBMET03288 0.309 0.046 DBMET03289 | DBMET03288 | |
| 0.264 | 0.027 | 0.264 | Insulin sensitizer | 0.162 0.118 DBMET03286 0.147 0.138 DBMET03287 0.147 0.138 DBMET03288 0.159 0.121 DBMET03289 | ||
| 0.354 | 0.119 | 0.592 | Cyclophilin D inhibitor | 0.592 0.029 DBMET03286 0.481 0.056 DBMET03289 | DBMET03286 | |
| 0.254 | 0.022 | 0.254 | Interleukin 6 antagonist | 0.178 0.056 DBMET03286 0.182 0.053 DBMET03287 0.182 0.053 DBMET03288 0.197 0.042 DBMET03289 | ||
| 0.294 | 0.092 | 0.656 | Antithrombotic | 0.656 0.011 DBMET03286 0.44 0.04 DBMET03289 | DBMET03286 | |
| 0.269 | 0.071 | 0.269 | DNA damaging | 0.263 0.074 DBMET03286 | ||
| 0.206 | 0.011 | 0.206 | Adenylate cyclase stimulant | 0.143 0.074 DBMET03286 0.129 0.104 DBMET03287 0.129 0.104 DBMET03288 | ||
| 0.247 | 0.055 | 0.247 | MAP kinase kinase 2 inhibitor | 0.148 0.123 DBMET03287 0.148 0.123 DBMET03288 | ||
| 0.205 | 0.014 | 0.205 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.208 | 0.032 | 0.215 | Insulin secretagoues | 0.207 0.032 DBMET03286 0.215 0.029 DBMET03289 | DBMET03289 | |
| 0.175 | 0.003 | 0.175 | Beta adrenoreceptor agonist | 0.045 0.032 DBMET03287 0.045 0.032 DBMET03288 | ||
| 0.175 | 0.004 | 0.175 | 5 Hydroxytryptamine 1B agonist | 0.055 0.034 DBMET03286 0.071 0.017 DBMET03287 0.071 0.017 DBMET03288 | ||
| 0.192 | 0.022 | 0.192 | Nav1.6 sodium channel blocker | |||
| 0.188 | 0.018 | 0.188 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.175 | 0.017 | 0.175 | Calcium antagonist | |||
| 0.219 | 0.061 | 0.219 | Nitric-oxide synthase stimulant | 0.182 0.124 DBMET03286 0.182 0.123 DBMET03287 0.182 0.123 DBMET03288 0.204 0.083 DBMET03289 | ||
| 0.182 | 0.032 | 0.182 | Toll-Like receptor 2 antagonist | |||
| 0.261 | 0.12 | 0.587 | Transcription factor NF kappa B inhibitor | 0.587 0.033 DBMET03286 0.303 0.092 DBMET03289 | DBMET03286 | |
| 0.181 | 0.048 | 0.181 | Cyclin-dependent kinase 3 inhibitor | 0.155 0.085 DBMET03287 0.155 0.085 DBMET03288 | ||
| 0.134 | 0.003 | 0.134 | Beta 3 adrenoreceptor agonist | |||
| 0.165 | 0.034 | 0.165 | Alpha adrenoreceptor antagonist | |||
| 0.222 | 0.092 | 0.387 | DNA synthesis inhibitor | 0.387 0.023 DBMET03286 0.284 0.05 DBMET03289 | DBMET03286 | |
| 0.224 | 0.093 | 0.486 | Hypoglycemic | 0.486 0.016 DBMET03286 0.389 0.029 DBMET03289 | DBMET03286 | |
| 0.143 | 0.019 | 0.143 | MAP kinase kinase 1 inhibitor | 0.084 0.08 DBMET03287 0.084 0.08 DBMET03288 | ||
| 0.154 | 0.031 | 0.154 | Nav1.1 sodium channel blocker | |||
| 0.261 | 0.144 | 0.261 | GABA C receptor rho-3 antagonist | |||
| 0.224 | 0.108 | 0.224 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.143 | 0.028 | 0.143 | Catalase inhibitor | 0.064 0.06 DBMET03287 0.064 0.06 DBMET03288 | ||
| 0.132 | 0.019 | 0.132 | Somatostatin 1 agonist | 0.088 0.043 DBMET03286 0.075 0.057 DBMET03287 0.075 0.057 DBMET03288 | ||
| 0.156 | 0.051 | 0.156 | MAP kinase kinase 4 inhibitor | 0.131 0.112 DBMET03287 0.131 0.112 DBMET03288 | ||
| 0.107 | 0.003 | 0.107 | Beta 1 adrenoreceptor agonist | 0.021 0.019 DBMET03287 0.021 0.019 DBMET03288 | ||
| 0.168 | 0.066 | 0.168 | Neurotensin receptor agonist | |||
| 0.224 | 0.124 | 0.225 | Insulysin inhibitor | 0.225 0.123 DBMET03287 0.225 0.123 DBMET03288 | DBMET03288 | |
| 0.104 | 0.006 | 0.104 | Sphingosine 1-phosphate receptor 3 agonist | 0.044 0.019 DBMET03287 0.044 0.019 DBMET03288 | ||
| 0.101 | 0.004 | 0.101 | Beta 2 adrenoreceptor agonist | |||
| 0.116 | 0.019 | 0.116 | Phenylalanine 4-hydroxylase inhibitor | 0.113 0.02 DBMET03287 0.113 0.02 DBMET03288 | ||
| 0.232 | 0.138 | 0.42 | Cholesterol antagonist | 0.42 0.046 DBMET03286 0.337 0.07 DBMET03289 | DBMET03286 | |
| 0.167 | 0.075 | 0.256 | ATPase inhibitor | 0.256 0.012 DBMET03286 0.179 0.059 DBMET03289 | DBMET03286 | |
| 0.146 | 0.057 | 0.199 | Alpha-N-acetylglucosaminidase inhibitor | 0.199 0.034 DBMET03286 0.189 0.037 DBMET03289 | DBMET03286 | |
| 0.203 | 0.118 | 0.493 | Immunostimulant | 0.493 0.03 DBMET03286 0.428 0.042 DBMET03289 | DBMET03286 | |
| 0.207 | 0.123 | 0.207 | Tyrosine 3 hydroxylase inhibitor | 0.197 0.14 DBMET03287 0.197 0.14 DBMET03288 | ||
| 0.087 | 0.004 | 0.087 | Calcium-sensing receptor antagonist | 0.015 0.01 DBMET03287 0.015 0.01 DBMET03288 | ||
| 0.14 | 0.057 | 0.14 | MAP kinase kinase inhibitor | |||
| 0.12 | 0.039 | 0.12 | Factor V inhibitor | 0.095 0.083 DBMET03286 | ||
| 0.138 | 0.058 | 0.138 | Antibacterial (Helicobacter pylori) | |||
| 0.123 | 0.044 | 0.206 | Mediator release inhibitor | 0.206 0.014 DBMET03286 0.098 0.073 DBMET03289 | DBMET03286 | |
| 0.237 | 0.16 | 0.435 | Immunosuppressant | 0.435 0.051 DBMET03286 0.358 0.082 DBMET03289 | DBMET03286 | |
| 0.142 | 0.066 | 0.142 | Calcium channel blocker | |||
| 0.134 | 0.058 | 0.134 | Aldehyde dehydrogenase inhibitor | 0.1 0.098 DBMET03286 0.104 0.091 DBMET03289 | ||
| 0.237 | 0.163 | 0.237 | Calcium channel activator | |||
| 0.079 | 0.009 | 0.079 | Sphingosine 1-phosphate receptor agonist | |||
| 0.107 | 0.041 | 0.107 | Alpha 1 adrenoreceptor antagonist | |||
| 0.185 | 0.12 | 0.331 | Peptidyltransferase inhibitor | 0.331 0.016 DBMET03286 0.324 0.018 DBMET03289 | DBMET03286 | |
| 0.114 | 0.049 | 0.176 | Toll-Like receptor 4 antagonist | 0.176 0.011 DBMET03286 0.104 0.063 DBMET03287 0.104 0.063 DBMET03288 0.151 0.02 DBMET03289 | DBMET03286 | |
| 0.1 | 0.035 | 0.1 | Myeloperoxidase inhibitor | |||
| 0.086 | 0.023 | 0.086 | 5 Hydroxytryptamine 2A agonist | |||
| 0.07 | 0.009 | 0.07 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.111 | 0.051 | 0.111 | Bronchodilator | |||
| 0.203 | 0.145 | 0.203 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.13 | 0.072 | 0.13 | Nav1.2 sodium channel blocker | |||
| 0.1 | 0.042 | 0.106 | Glutamate release inhibitor | 0.106 0.034 DBMET03286 | DBMET03286 | |
| 0.086 | 0.03 | 0.086 | Fibroblast growth factor 2 antagonist | |||
| 0.087 | 0.03 | 0.087 | Phosphodiesterase III inhibitor | |||
| 0.11 | 0.054 | 0.11 | Gastric antisecretory | |||
| 0.102 | 0.05 | 0.102 | Protein kinase C delta inhibitor | |||
| 0.089 | 0.037 | 0.089 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.105 | 0.056 | 0.105 | GABA C receptor rho-1 antagonist | |||
| 0.088 | 0.041 | 0.088 | Alpha 1b adrenoreceptor antagonist | |||
| 0.086 | 0.041 | 0.086 | Keratolytic | |||
| 0.065 | 0.024 | 0.065 | Myc inhibitor | |||
| 0.093 | 0.053 | 0.093 | Aminoacyl-tRNA synthetase inhibitor | 0.083 0.072 DBMET03287 0.083 0.072 DBMET03288 | ||
| 0.09 | 0.051 | 0.09 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.074 | 0.038 | 0.074 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.084 | 0.05 | 0.118 | Topoisomerase II alpha inhibitor | 0.118 0.03 DBMET03286 0.109 0.034 DBMET03289 | DBMET03286 | |
| 0.104 | 0.07 | 0.104 | Nav1.4 sodium channel blocker | |||
| 0.1 | 0.066 | 0.1 | Protease inhibitor | |||
| 0.094 | 0.061 | 0.094 | Toll-Like receptor 3 antagonist | |||
| 0.085 | 0.055 | 0.085 | Histamine H2 receptor antagonist | |||
| 0.064 | 0.034 | 0.064 | Heat shock protein 90 beta antagonist | |||
| 0.063 | 0.033 | 0.063 | Protein kinase C theta inhibitor | |||
| 0.04 | 0.013 | 0.04 | Plasmepsin I inhibitor | |||
| 0.072 | 0.046 | 0.072 | Secretase beta inhibitor | |||
| 0.06 | 0.034 | 0.06 | Cathepsin D inhibitor | |||
| 0.063 | 0.039 | 0.063 | Alpha 1d adrenoreceptor antagonist | |||
| 0.083 | 0.06 | 0.083 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.123 | 0.1 | 0.123 | Aurora-C kinase inhibitor | |||
| 0.056 | 0.034 | 0.056 | 5 Hydroxytryptamine 1 agonist | |||
| 0.089 | 0.067 | 0.089 | Protein kinase C zeta inhibitor | |||
| 0.104 | 0.084 | 0.197 | Alkylator | 0.197 0.027 DBMET03286 0.1 0.089 DBMET03289 | DBMET03286 | |
| 0.129 | 0.109 | 0.129 | Growth hormone agonist | |||
| 0.082 | 0.063 | 0.082 | NMDA receptor antagonist | |||
| 0.031 | 0.013 | 0.031 | Dopamine autoreceptor agonist | |||
| 0.05 | 0.033 | 0.05 | Bombesin 2 receptor antagonist | |||
| 0.081 | 0.064 | 0.081 | Alpha 2 adrenoreceptor antagonist | |||
| 0.054 | 0.039 | 0.054 | Epithelial sodium channel blocker | |||
| 0.12 | 0.105 | 0.12 | Diuretic | 0.115 0.111 DBMET03286 | ||
| 0.081 | 0.066 | 0.081 | Ornithine decarboxylase inhibitor | |||
| 0.127 | 0.112 | 0.127 | GABA C receptor rho-2 antagonist | |||
| 0.06 | 0.047 | 0.06 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.093 | 0.08 | 0.093 | Adenylate kinase inhibitor | |||
| 0.068 | 0.057 | 0.068 | Phospholipase D inhibitor | |||
| 0.095 | 0.084 | 0.095 | 5 Hydroxytryptamine antagonist | |||
| 0.152 | 0.142 | 0.152 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.092 | 0.083 | 0.092 | Folate antagonist | |||
| 0.136 | 0.128 | 0.136 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.061 | 0.053 | 0.061 | Calcium channel P-type blocker | |||
| 0.096 | 0.089 | 0.096 | CDC-like kinase 3 inhibitor | |||
| 0.199 | 0.192 | 0.413 | Interleukin 2 agonist | 0.413 0.024 DBMET03286 0.362 0.04 DBMET03289 | DBMET03286 | |
| 0.088 | 0.081 | 0.088 | Insulin receptor antagonist | |||
| 0.065 | 0.06 | 0.065 | Aminopeptidase I inhibitor | |||
| 0.085 | 0.08 | 0.085 | Creatine kinase inhibitor | |||
| 0.085 | 0.08 | 0.167 | UDP-glucose 4-epimerase inhibitor | 0.162 0.025 DBMET03286 0.167 0.024 DBMET03289 | DBMET03289 | |
| 0.04 | 0.036 | 0.04 | GABA B receptor antagonist | |||
| 0.064 | 0.061 | 0.064 | Calcium channel L-type blocker | |||
| 0.06 | 0.058 | 0.06 | Alpha 1a adrenoreceptor antagonist | |||
| 0.119 | 0.117 | 0.119 | MAP3K9 inhibitor | |||
| 0.095 | 0.094 | 0.095 | Nav1.5 sodium channel blocker | |||
| 0.081 | 0.08 | 0.081 | Prolactin inhibitor | |||
| 0.091 | 0.093 | 0.367 | Interleukin 1b antagonist | 0.367 0.005 DBMET03287 0.367 0.005 DBMET03288 0.244 0.013 DBMET03289 | DBMET03288 | |
| 0.09 | 0.096 | 0.184 | Topoisomerase II inhibitor | 0.184 0.037 DBMET03286 0.151 0.049 DBMET03289 | DBMET03286 | |
| 0.076 | 0.085 | 0.113 | Triose-phosphate isomerase inhibitor | 0.108 0.04 DBMET03286 0.113 0.037 DBMET03289 | DBMET03289 | |
| 0.05 | 0.06 | 0.308 | Selectin antagonist | 0.308 0.005 DBMET03286 0.251 0.008 DBMET03289 | DBMET03286 | |
| 0.11 | 0.123 | 0.234 | Thrombolytic | 0.234 0.038 DBMET03286 0.196 0.054 DBMET03289 | DBMET03286 | |
| 0.074 | 0.089 | 0.083 | Aminopeptidase B inhibitor | 0.083 0.078 DBMET03287 0.083 0.078 DBMET03288 | DBMET03288 | |
| 0.075 | 0.093 | 0.096 | ATPase (Vacuolar H+) inhibitor | 0.09 0.055 DBMET03286 0.096 0.045 DBMET03289 | DBMET03289 | |
| 0.082 | 0.101 | 0.096 | Phosphodiesterase 6D inhibitor | 0.096 0.06 DBMET03286 | DBMET03286 | |
| 0.091 | 0.11 | 0.117 | Microtubule formation inhibitor | 0.117 0.064 DBMET03286 | DBMET03286 | |
| 0.035 | 0.056 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.05 0.023 DBMET03286 0.042 0.039 DBMET03289 | DBMET03286 | |
| 0.139 | 0.162 | 0.295 | Antiamyloidogenic | 0.295 0.053 DBMET03286 | DBMET03286 | |
| 0.018 | 0.045 | 0.069 | Renin inhibitor | 0.069 0.01 DBMET03287 0.069 0.01 DBMET03288 | DBMET03288 | |
| 0.014 | 0.045 | 0.028 | Squalene synthetase inhibitor | 0.028 0.025 DBMET03286 | DBMET03286 | |
| 0.142 | 0.174 | 0.287 | Interleukin agonist | 0.287 0.055 DBMET03286 0.241 0.085 DBMET03289 | DBMET03286 | |
| 0.069 | 0.103 | 0.127 | NADH dehydrogenase inhibitor | 0.127 0.025 DBMET03286 0.112 0.034 DBMET03289 | DBMET03286 | |
| 0.168 | 0.205 | 0.395 | Immunomodulator | 0.395 0.045 DBMET03286 0.226 0.136 DBMET03289 | DBMET03286 | |
| 0.096 | 0.135 | 0.31 | Interleukin 1 antagonist | 0.31 0.01 DBMET03287 0.31 0.01 DBMET03288 0.217 0.027 DBMET03289 | DBMET03288 | |
| 0.074 | 0.115 | 0.108 | DNA intercalator | 0.108 0.066 DBMET03286 | DBMET03286 | |
| 0.037 | 0.081 | 0.058 | Alpha-mannosidase inhibitor | 0.05 0.043 DBMET03286 0.058 0.029 DBMET03289 | DBMET03289 | |
| 0.027 | 0.074 | 0.055 | Mannosidase inhibitor | 0.044 0.033 DBMET03286 0.055 0.02 DBMET03289 | DBMET03289 | |
| 0.045 | 0.103 | 0.082 | Neuraminidase (influenza) inhibitor | 0.082 0.024 DBMET03286 | DBMET03286 | |
| 0.011 | 0.074 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.01 DBMET03286 | DBMET03286 | |
| 0.037 | 0.101 | 0.093 | Nitric oxide donor | 0.093 0.013 DBMET03289 | DBMET03289 | |
| 0.081 | 0.148 | 0.185 | Lipid peroxidase inhibitor | 0.185 0.048 DBMET03286 0.166 0.058 DBMET03289 | DBMET03286 | |
| 0.07 | 0.138 | 0.203 | AMP-activated protein kinase stimulant | 0.203 0.01 DBMET03286 0.108 0.06 DBMET03289 | DBMET03286 | |
| 0.167 | 0.236 | 0.407 | Apoptosis antagonist | 0.407 0.036 DBMET03286 0.295 0.088 DBMET03289 | DBMET03286 | |
| 0.017 | 0.087 | 0.038 | HMG CoA reductase inhibitor | 0.038 0.017 DBMET03287 0.038 0.017 DBMET03288 0.035 0.022 DBMET03289 | DBMET03288 | |
| 0.059 | 0.139 | 0.125 | Expectorant | 0.125 0.047 DBMET03286 0.119 0.052 DBMET03289 | DBMET03286 | |
| 0.066 | 0.152 | 0.252 | Amylase inhibitor | 0.252 0.028 DBMET03286 0.135 0.072 DBMET03289 | DBMET03286 | |
| 0.027 | 0.115 | 0.068 | Neuraminidase inhibitor | 0.068 0.035 DBMET03286 | DBMET03286 | |
| 0.084 | 0.178 | 0.617 | Angiogenesis stimulant | 0.482 0.013 DBMET03286 0.617 0.006 DBMET03289 | DBMET03289 | |
| 0.118 | 0.214 | 0.418 | Antioxidant | 0.418 0.032 DBMET03286 0.335 0.05 DBMET03289 | DBMET03286 | |
| 0.021 | 0.118 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 DBMET03286 0.051 0.012 DBMET03289 | DBMET03286 | |
| 0.108 | 0.207 | 0.222 | Platelet antagonist | 0.222 0.086 DBMET03286 0.171 0.125 DBMET03289 | DBMET03286 | |
| 0.063 | 0.164 | 0.164 | Beta glucuronidase inhibitor | 0.164 0.02 DBMET03286 0.132 0.036 DBMET03289 | DBMET03286 | |
| 0.016 | 0.122 | 0.042 | Phosphorylase inhibitor | 0.042 0.035 DBMET03286 | DBMET03286 | |
| 0.055 | 0.164 | 0.085 | Cyclin-dependent kinase 9 inhibitor | 0.085 0.082 DBMET03287 0.085 0.082 DBMET03288 | DBMET03288 | |
| 0.152 | 0.27 | 0.202 | Caspase 3 stimulant | 0.202 0.165 DBMET03286 | DBMET03286 | |
| 0.089 | 0.21 | 0.338 | Hemostatic | 0.338 0.013 DBMET03286 | DBMET03286 | |
| 0.016 | 0.144 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 DBMET03286 0.027 0.018 DBMET03289 | DBMET03286 | |
| 0.176 | 0.312 | 0.472 | Apoptosis agonist | 0.472 0.083 DBMET03286 0.392 0.118 DBMET03289 | DBMET03286 | |
| 0.072 | 0.208 | 0.134 | Amyloid beta aggregation inhibitor | 0.134 0.122 DBMET03286 | DBMET03286 | |
| 0.091 | 0.234 | 0.142 | Interferon gamma antagonist | 0.142 0.089 DBMET03286 0.133 0.105 DBMET03289 | DBMET03286 | |
| 0.052 | 0.205 | 0.109 | Transcription factor NF kappa B stimulant | 0.109 0.032 DBMET03286 0.098 0.041 DBMET03289 | DBMET03286 | |
| 0.019 | 0.181 | 0.125 | Antineoplastic antibiotic | 0.125 0.037 DBMET03286 0.091 0.05 DBMET03289 | DBMET03286 | |
| 0.079 | 0.241 | 0.291 | Platelet adhesion inhibitor | 0.291 0.037 DBMET03286 0.222 0.06 DBMET03289 | DBMET03286 | |
| 0.079 | 0.243 | 0.282 | Nitric oxide antagonist | 0.282 0.044 DBMET03286 0.193 0.07 DBMET03289 | DBMET03286 | |
| 0.083 | 0.249 | 0.264 | Hypolipemic | 0.164 0.123 DBMET03286 0.167 0.121 DBMET03287 0.167 0.121 DBMET03288 0.264 0.062 DBMET03289 | DBMET03289 | |
| 0.048 | 0.225 | 0.115 | DNA polymerase I inhibitor | 0.115 0.072 DBMET03286 | DBMET03286 | |
| 0.085 | 0.262 | 0.465 | Free radical scavenger | 0.384 0.032 DBMET03286 0.289 0.055 DBMET03287 0.289 0.055 DBMET03288 0.465 0.02 DBMET03289 | DBMET03289 | |
| 0.024 | 0.207 | 0.057 | Glucose-6-phosphate translocase inhibitor | 0.057 0.028 DBMET03286 0.05 0.039 DBMET03289 | DBMET03286 | |
| 0.032 | 0.215 | 0.138 | Topoisomerase I inhibitor | 0.138 0.046 DBMET03286 0.116 0.058 DBMET03289 | DBMET03286 | |
| 0.008 | 0.195 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.02 DBMET03286 | DBMET03286 | |
| 0.084 | 0.273 | 0.325 | Tumour necrosis factor alpha release inhibitor | 0.325 0.045 DBMET03286 0.312 0.049 DBMET03287 0.312 0.049 DBMET03288 0.3 0.053 DBMET03289 | DBMET03286 | |
| 0.023 | 0.219 | 0.076 | Heparanase inhibitor | 0.076 0.008 DBMET03286 0.054 0.035 DBMET03289 | DBMET03286 | |
| 0.026 | 0.226 | 0.123 | Monophenol monooxygenase inhibitor | 0.123 0.059 DBMET03286 | DBMET03286 | |
| 0.052 | 0.272 | 0.129 | Cyclooxygenase 3 inhibitor | 0.126 0.071 DBMET03286 0.129 0.068 DBMET03289 | DBMET03289 | |
| 0.059 | 0.281 | 0.154 | Cell wall synthesis inhibitor | 0.154 0.062 DBMET03286 0.134 0.081 DBMET03289 | DBMET03286 | |
| 0.008 | 0.231 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.025 0.016 DBMET03286 | DBMET03286 | |
| 0.031 | 0.257 | 0.073 | Adenine nucleotide translocase inhibitor | 0.073 0.013 DBMET03286 | DBMET03286 | |
| 0.022 | 0.261 | 0.052 | Factor IXa inhibitor | 0.051 0.036 DBMET03286 0.052 0.034 DBMET03289 | DBMET03289 | |
| 0.019 | 0.258 | 0.1 | Leukotriene synthesis inhibitor | 0.1 0.026 DBMET03287 0.1 0.026 DBMET03288 | DBMET03288 | |
| 0.118 | 0.359 | 0.545 | Antibacterial | 0.541 0.031 DBMET03286 0.254 0.173 DBMET03287 0.254 0.173 DBMET03288 0.545 0.03 DBMET03289 | DBMET03289 | |
| 0.048 | 0.308 | 0.166 | Anticoagulant | 0.166 0.068 DBMET03286 0.123 0.108 DBMET03289 | DBMET03286 | |
| 0.066 | 0.331 | 0.125 | DNA repair enzyme inhibitor | 0.125 0.062 DBMET03286 0.107 0.104 DBMET03289 | DBMET03286 | |
| 0.014 | 0.286 | 0.078 | Protein 50S ribosomal subunit inhibitor | 0.078 0.02 DBMET03286 0.058 0.033 DBMET03289 | DBMET03286 | |
| 0.061 | 0.339 | 0.32 | Hepatoprotectant | 0.32 0.024 DBMET03286 0.259 0.041 DBMET03289 | DBMET03286 | |
| 0.009 | 0.298 | 0.081 | Opioid agonist | 0.081 0.019 DBMET03289 | DBMET03289 | |
| 0.081 | 0.378 | 0.216 | Angiogenesis inhibitor | 0.216 0.152 DBMET03286 | DBMET03286 | |
| 0.019 | 0.327 | 0.215 | Analgesic, opioid | 0.215 0.009 DBMET03289 | DBMET03289 | |
| 0.054 | 0.4 | 0.158 | NOS3 expression enhancer | 0.158 0.065 DBMET03286 0.138 0.086 DBMET03289 | DBMET03286 | |
| 0.037 | 0.396 | 0.12 | Cell adhesion inhibitor | 0.12 0.065 DBMET03286 | DBMET03286 | |
| 0.039 | 0.492 | 0.341 | Lipoxygenase inhibitor | 0.341 0.053 DBMET03287 0.341 0.053 DBMET03288 | DBMET03288 | |
| 0.005 | 0.471 | 0.204 | Opioid kappa receptor agonist | 0.204 0.004 DBMET03289 | DBMET03289 | |
| 0.01 | 0.491 | 0.584 | 5-Lipoxygenase inhibitor | 0.584 0.004 DBMET03287 0.584 0.004 DBMET03288 | DBMET03288 | |
| 0.049 | 0.686 | 0.647 | Antiinflammatory | 0.484 0.094 DBMET03286 0.347 0.175 DBMET03287 0.347 0.175 DBMET03288 0.647 0.041 DBMET03289 | DBMET03289 | |
| 0.068 | 0.714 | 0.12 | CC chemokine 6 receptor antagonist | 0.12 0.118 DBMET03286 | DBMET03286 | |
| 0.03 | 0.714 | 0.322 | Analgesic | 0.322 0.125 DBMET03289 | DBMET03289 | |
| 0.007 | 0.75 | 0.235 | Cyclooxygenase inhibitor | 0.235 0.03 DBMET03287 0.235 0.03 DBMET03288 | DBMET03288 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |